TIVDAK
NDC 51144-003, tisotumab vedotin, injection, powder, for solution, from SEAGEN INC..
- Product NDC
- 51144-003
- Status
- Listed
- Labeler
- SEAGEN INC.
- Dosage form
- INJECTION, POWDER, FOR SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761208
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51144-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TISOTUMAB VEDOTIN40 mg/4mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51144-003-01 | 51144000301 | 1 VIAL in 1 CARTON (51144-003-01) / 4 mL in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c9fe3f32-4219-466e-acb9-3f609b4f4df1Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=51144-003
Use it
Look up 51144-003 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51144-003 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51144-003. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.